Maya S Sheth

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Prognostic Factors

Clinical Practice

Peripheral Artery Disease

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association 11 (24) (2022)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association (2022)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association 11 (24) (2022)
Maya S Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E Legere, Shaun G Goodman, Michael E Farkouh, Dennis T Ko, Husam Abdel-Qadir, Jacob A Udell
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study. Journal of the American Heart Association 11 (24) (2022)